457 related articles for article (PubMed ID: 20708037)
1. Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.
Eckstein A; Grössl T; Geisler A; Wang X; Pinkert S; Pozzuto T; Schwer C; Kurreck J; Weger S; Vetter R; Poller W; Fechner H
Antiviral Res; 2010 Oct; 88(1):86-94. PubMed ID: 20708037
[TBL] [Abstract][Full Text] [Related]
2. Silencing E1A mRNA by RNA interference inhibits adenovirus replication.
Chung YS; Kim MK; Lee WJ; Kang C
Arch Virol; 2007; 152(7):1305-14. PubMed ID: 17597352
[TBL] [Abstract][Full Text] [Related]
3. Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir.
Pozzuto T; Röger C; Kurreck J; Fechner H
Antiviral Res; 2015 Aug; 120():72-8. PubMed ID: 26026665
[TBL] [Abstract][Full Text] [Related]
4. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
Sun Y; Li Z; Li L; Li J; Liu X; Li W
Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of viral replication by adenoviral-mediated expression of siRNA against cellular cofactors for hepatitis C virus.
Zhang J; Yamada O; Sakamoto T; Yoshida H; Iwai T; Matsushita Y; Shimamura H; Araki H; Shimotohno K
Virology; 2004 Mar; 320(1):135-43. PubMed ID: 15003869
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of adenovirus multiplication by short interfering RNAs directly or indirectly targeting the viral DNA replication machinery.
Kneidinger D; Ibrišimović M; Lion T; Klein R
Antiviral Res; 2012 Jun; 94(3):195-207. PubMed ID: 22510340
[TBL] [Abstract][Full Text] [Related]
7. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production.
Aparicio O; Razquin N; Zaratiegui M; Narvaiza I; Fortes P
J Virol; 2006 Feb; 80(3):1376-84. PubMed ID: 16415015
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus double-stranded RNA-binding protein E3 does not interfere with siRNA-mediated gene silencing in mammalian cells.
Lantermann M; Schwantes A; Sliva K; Sutter G; Schnierle BS
Virus Res; 2007 Jun; 126(1-2):1-8. PubMed ID: 17306404
[TBL] [Abstract][Full Text] [Related]
10. Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo.
Rivera AA; Wang M; Suzuki K; Uil TG; Krasnykh V; Curiel DT; Nettelbeck DM
Virology; 2004 Mar; 320(1):121-34. PubMed ID: 15003868
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of rabies virus multiplication by siRNA delivered through adenoviral vector in vitro in BHK-21 cells and in vivo in mice.
Sonwane AA; Dahiya SS; Saini M; Chaturvedi VK; Singh RP; Gupta PK
Res Vet Sci; 2012 Aug; 93(1):498-503. PubMed ID: 21767857
[TBL] [Abstract][Full Text] [Related]
12. Developing an effective RNA interference strategy against a plus-strand RNA virus: silencing of coxsackievirus B3 and its cognate coxsackievirus-adenovirus receptor.
Werk D; Schubert S; Lindig V; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
Biol Chem; 2005 Sep; 386(9):857-63. PubMed ID: 16164410
[TBL] [Abstract][Full Text] [Related]
13. Specific inhibition of orthopoxvirus replication by a small interfering RNA targeting the D5R gene.
Vigne S; Germi R; Duraffour S; Larrat S; Andrei G; Snoeck R; Garin D; Crance JM
Antivir Ther; 2008; 13(3):357-68. PubMed ID: 18572748
[TBL] [Abstract][Full Text] [Related]
14. Small interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse model.
Reich SJ; Fosnot J; Kuroki A; Tang W; Yang X; Maguire AM; Bennett J; Tolentino MJ
Mol Vis; 2003 May; 9():210-6. PubMed ID: 12789138
[TBL] [Abstract][Full Text] [Related]
15. Specific HIV-1 env gene silencing by small interfering RNAs in human peripheral blood mononuclear cells.
Park WS; Hayafune M; Miyano-Kurosaki N; Takaku H
Gene Ther; 2003 Nov; 10(24):2046-50. PubMed ID: 14566364
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
Kim M; Shin D; Kim SI; Park M
Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
[TBL] [Abstract][Full Text] [Related]
17. A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
Li Y; Yu DC; Chen Y; Amin P; Zhang H; Nguyen N; Henderson DR
Cancer Res; 2001 Sep; 61(17):6428-36. PubMed ID: 11522637
[TBL] [Abstract][Full Text] [Related]
18. Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs.
Schubert S; Grunert HP; Zeichhardt H; Werk D; Erdmann VA; Kurreck J
J Mol Biol; 2005 Feb; 346(2):457-65. PubMed ID: 15670596
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of adenoviral vectors for delivery of expressed RNAi activators.
Mowa MB; Crowther C; Arbuthnot P
Expert Opin Drug Deliv; 2010 Dec; 7(12):1373-85. PubMed ID: 21073358
[TBL] [Abstract][Full Text] [Related]
20. Novel oncolytic adenoviruses targeted to melanoma: specific viral replication and cytolysis by expression of E1A mutants from the tyrosinase enhancer/promoter.
Nettelbeck DM; Rivera AA; Balagué C; Alemany R; Curiel DT
Cancer Res; 2002 Aug; 62(16):4663-70. PubMed ID: 12183423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
